WuXi AppTec is pleased to unveil its new complimentary webinar series, “Collaborations That Transform,” which will highlight the impact of collaborations to bring meaningful and effective therapies to patients. In honor of World Neurofibromatosis (NF) Awareness Month this May, we are delighted to kick off this series with a multi-track program on the rare disease neurofibromatosis through diverse perspectives from leading clinicians, drug developers, patients, and non-profit foundations.
7AM – 9AM PDT | 10AM – 12PM EDT | 4PM – 6PM CET | 10PM – 12AM Beijing Time
In this educational webinar, BGI’s Senior Research and Engineering Manager, Dr. Jiang, will review what we currently know of the genetic diversity of SARS-CoV-2 from evolutionary analysis. He will then present relevant sequencing solutions and research strategies that are helping scientists understand more about the molecular epidemiology of the virus for applications including general clinical research, vaccine development and drug R&D.
what we know of the genetic diversity of the virus from evolutionary analysis – current SARS-CoV-2 databases and resources – common challenges in infectious disease genomics research – practical guidance regarding coverage and sampling protocols for relevant sequencing solutions, including: • whole genome sequencing • single cell sequencing • metagenomics sequencing – how sequencing can be applied for vaccine development, drug R&D and clinical research.
The HKEX Biotech 2020 webinar series will kick off on 26 May, with a look at the latest biotech trends in Asia, listing opportunities for new economy and innovative companies, and an update on the latest biotech regulations. Registration is now open! Don’t miss the chance to explore the latest industry trends and opportunities together! Register Now
Opening Remarks: Bonnie Y Chan – Head of Listing, HKEX Regulatory Presentation: Patrick Lam – Assistant Vice President, IPO Vetting, HKEX Wei Zhang – Assistant Vice President, IPO Vetting, HKEX Panel Discussion: Nisa Leung – Managing Partner, Qiming Venture Partners Bin Li – Founding partner & CIO, Lake Bleu Capital Ronnie Ede – Executive Director & CFO, Innovent Biologics Daniel Wong – Director & Head of Research and Analytics, Hang Seng Indexes Co Moderator: Christina Bao – Managing Director & Head of Global Issuer Services, HKEX
In this educational webinar, BGI’s Senior Research and Engineering Manager, Dr. Jiang, will review what we currently know of the genetic diversity of SARS-CoV-2 from evolutionary analysis. He will then present relevant sequencing solutions and research strategies that are helping scientists understand more about the molecular epidemiology of the virus for applications including general clinical research, vaccine development and drug R&D.
what we know of the genetic diversity of the virus from evolutionary analysis – current SARS-CoV-2 databases and resources – common challenges in infectious disease genomics research – practical guidance regarding coverage and sampling protocols for relevant sequencing solutions, including: • whole genome sequencing • single cell sequencing • metagenomics sequencing – how sequencing can be applied for vaccine development, drug R&D and clinical research.
The HKEX Biotech 2020 webinar series will kick off on 26 May, with a look at the latest biotech trends in Asia, listing opportunities for new economy and innovative companies, and an update on the latest biotech regulations. Registration is now open! Don’t miss the chance to explore the latest industry trends and opportunities together! Register Now
Opening Remarks: Bonnie Y Chan – Head of Listing, HKEX Regulatory Presentation: Patrick Lam – Assistant Vice President, IPO Vetting, HKEX Wei Zhang – Assistant Vice President, IPO Vetting, HKEX Panel Discussion: Nisa Leung – Managing Partner, Qiming Venture Partners Bin Li – Founding partner & CIO, Lake Bleu Capital Ronnie Ede – Executive Director & CFO, Innovent Biologics Daniel Wong – Director & Head of Research and Analytics, Hang Seng Indexes Co Moderator: Christina Bao – Managing Director & Head of Global Issuer Services, HKEX
It has been more than a hundred days since Chinese researchers posted the genetic sequence for the SARS-CoV2 virus to a public database, setting off the biggest and fastest race to create vaccines the world has ever seen. One of the defining features of the race is diversity — of vaccine modalities, types of organizations developing them, and geographic distribution of R&D and manufacturing. So far, at least six vaccines have made it into the clinic. We have reached the end of the beginning: What comes next?
In this exclusive webinar, BioCentury, BioKatalyst and Lonza bring together industry and policy leaders to discuss how to accelerate COVID-19 vaccine development.
William “Bill” Enright – Director and CEO | Vaccitech, Ltd.
Nicole Lurie, M.D., M.S.P.H.: Strategic Advisor, CEPI (The Coalition for Epidemic Preparedness Innovation); and former Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services
Xuefeng YU, Ph.D : Co-founder, Chairman and CEO | CanSino Biologics Inc.
The second Biotech by the Lake Investor Summit (now digital), hosted by the Chemistry of Life Processes Institute at Northwestern University, Oppenheimer & Co and BioCentury, will provide an exclusive look at next-generation cancer therapies and technologies.
Esco Ventures合作邀请国际大咖『直播交流不带货』～感兴趣罕见病、基因治疗的小伙伴赶紧预约小板凳～Welcome to join us 注册加入
【Harvey F. Lodish】 美国国家科学院院士、Whitehead生物医学研究所的创始成员、麻省理工学院生物系教授和生物工程系教授 波士顿儿童医院董事会董事、 曾担任美国细胞生物学学会的主席、2017年获得美国细胞生物学学会颁发的 The Sandra K. Masur Senior Leadership Award
The second Biotech by the Lake Investor Summit (now digital), hosted by the Chemistry of Life Processes Institute at Northwestern University, Oppenheimer & Co and BioCentury, will provide an exclusive look at next-generation cancer therapies and technologies.
Esco Ventures合作邀请国际大咖『直播交流不带货』～感兴趣罕见病、基因治疗的小伙伴赶紧预约小板凳～Welcome to join us 注册加入
【Harvey F. Lodish】 美国国家科学院院士、Whitehead生物医学研究所的创始成员、麻省理工学院生物系教授和生物工程系教授 波士顿儿童医院董事会董事、 曾担任美国细胞生物学学会的主席、2017年获得美国细胞生物学学会颁发的 The Sandra K. Masur Senior Leadership Award
Regulations are made by the government to protect public health by ensuring the safety and efficacy of medicines, vaccines, and medical devices. This talk aims to benefit regulators in start-ups or those keen to pursue regulatory affairs as a career. We invite you to join us in this webinar series on regulatory affairs to get a global perspective from regulators in different parts of the world.
Speaker:
Jack Wong: Founder of ARPA @Asia Regulatory Professionals AssociationOver 25 years of Regulatory, Quality, Clinical Trial and Pharmacovigilance experience in Asia with good knowledge in the field of Medical Devices, Pharmaceuticals, Nutritional, Consumer Healthcare and Biological products
